Sunshine Biopharma (NASDAQ: SBFM) reported Q4 2023 earnings per share (EPS) of -$5.70, up 96.2% year over year. Total Sunshine Biopharma earnings for the quarter were -$1.25 million. In the same quarter last year, Sunshine Biopharma's earnings per share (EPS) was -$150.00.
As of Q2 2024, Sunshine Biopharma's earnings has grown year over year. Sunshine Biopharma's earnings in the past year totalled -$4.51 million.
What is SBFM's earnings date?
Sunshine Biopharma's earnings date is Invalid Date. Add SBFM to your watchlist to be reminded of SBFM's next earnings announcement.
What was SBFM's revenue last quarter?
Sunshine Biopharma (NASDAQ: SBFM) reported Q4 2023 revenue of $7.68 million up 94.94% year over year. In the same quarter last year, Sunshine Biopharma's revenue was $3.94 million.
What was SBFM's revenue growth in the past year?
As of Q2 2024, Sunshine Biopharma's revenue has grown 454.42% year over year. This is 444.23 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.18%. Sunshine Biopharma's revenue in the past year totalled $24.09 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.